LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,216,771 | +10.5% | 47,890 | +13.5% | 0.01% | +12.5% |
| Q2 2023 | $2,912,376 | +110.5% | 42,190 | +47.1% | 0.01% | +100.0% |
| Q1 2023 | $1,383,432 | -12.5% | 28,690 | -9.5% | 0.00% | -20.0% |
| Q4 2022 | $1,581,965 | +45.3% | 31,690 | +18.7% | 0.01% | +66.7% |
| Q3 2022 | $1,089,000 | -45.9% | 26,700 | -27.0% | 0.00% | -50.0% |
| Q2 2022 | $2,013,000 | +6.5% | 36,600 | -29.7% | 0.01% | +20.0% |
| Q1 2022 | $1,891,000 | +65.6% | 52,039 | +112.4% | 0.01% | +66.7% |
| Q4 2021 | $1,142,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |